Overview

Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging

Status:
Terminated

Trial end date:
2021-01-06

Target enrollment:

Participant gender:

Summary

[18F] FMISO Positron Emission Tomography (PET) to determine hypoxia in patients with HCC treated with TACE.

Phase:

Phase 2

Details

Lead Sponsor:

University of Alabama at Birmingham